Back to Journals » Vascular Health and Risk Management » Volume 8

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders

Total article views   Abstract views HTML views PDF downloads Totals
12,515 Dovepress* 7,760 388+ 2,424 8,148
PubMed Central* 20 4,347 2,404 4,367
Totals 7,780 4,735 4,828 12,515
*Since 25 January 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar